Literature DB >> 15801569

Human functional neuroimaging in nicotine and tobacco research: basics, background, and beyond.

F Joseph McClernon1, David G Gilbert.   

Abstract

Modern functional neuroimaging techniques allow nicotine and tobacco researchers to investigate the neurobiological basis of addiction in humans. We introduce the methods and measures of the following neuroimaging techniques: Electroencephalography and event-related cortical potentials, positron emission tomography, and functional magnetic resonance imaging. We outline strengths and limitations across modalities and describe new and emerging technologies. We provide summaries of recent neuroimaging findings in the field of nicotine and tobacco research for neurochemistry, smoking and nicotine administration, craving and cue-reactivity, cognitive and affective information processing, and tobacco withdrawal. We address limitations of studies to date and identify opportunities for future research.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15801569     DOI: 10.1080/14622200412331337394

Source DB:  PubMed          Journal:  Nicotine Tob Res        ISSN: 1462-2203            Impact factor:   4.244


  17 in total

Review 1.  Neuroimaging, genetics and the treatment of nicotine addiction.

Authors:  Riju Ray; James Loughead; Ze Wang; John Detre; Edward Yang; Ruben Gur; Caryn Lerman
Journal:  Behav Brain Res       Date:  2008-06-05       Impact factor: 3.332

2.  Neural substrates of smoking cue reactivity: a meta-analysis of fMRI studies.

Authors:  Jeffrey M Engelmann; Francesco Versace; Jason D Robinson; Jennifer A Minnix; Cho Y Lam; Yong Cui; Victoria L Brown; Paul M Cinciripini
Journal:  Neuroimage       Date:  2011-12-21       Impact factor: 6.556

3.  Trial-by-Trial Fluctuations in Brain Responses to Stress Predict Subsequent Smoking Decisions That Occur Several Seconds Later.

Authors:  Seung-Lark Lim; Laura E Martin; Delwyn Catley
Journal:  Biol Psychiatry Cogn Neurosci Neuroimaging       Date:  2020-06-27

4.  Distinct Roles of CREB Within the Ventral and Dorsal Hippocampus in Mediating Nicotine Withdrawal Phenotypes.

Authors:  Miranda L Fisher; Rachel M LeMalefant; Luyi Zhou; Gavin Huang; Jill R Turner
Journal:  Neuropsychopharmacology       Date:  2016-11-16       Impact factor: 7.853

5.  Smoking withdrawal modulates right inferior frontal cortex but not presupplementary motor area activation during inhibitory control.

Authors:  Rachel V Kozink; Scott H Kollins; F Joseph McClernon
Journal:  Neuropsychopharmacology       Date:  2010-09-22       Impact factor: 7.853

6.  Divergent functional effects of sazetidine-a and varenicline during nicotine withdrawal.

Authors:  Jill R Turner; Derek S Wilkinson; Rachel Lf Poole; Thomas J Gould; Gregory C Carlson; Julie A Blendy
Journal:  Neuropsychopharmacology       Date:  2013-04-29       Impact factor: 7.853

7.  Reduced fronto-cerebellar functional connectivity in chronic alcoholic patients.

Authors:  Baxter P Rogers; Mitchell H Parks; Mark K Nickel; Santosh B Katwal; Peter R Martin
Journal:  Alcohol Clin Exp Res       Date:  2011-11-15       Impact factor: 3.455

8.  Neural substrates of alcohol-induced smoking urge in heavy drinking nondaily smokers.

Authors:  Andrea King; Patrick McNamara; Michael Angstadt; K Luan Phan
Journal:  Neuropsychopharmacology       Date:  2009-11-11       Impact factor: 7.853

9.  Identifying the molecular basis of inhibitory control deficits in addictions: neuroimaging in non-human primates.

Authors:  Stephanie M Groman; J David Jentsch
Journal:  Curr Opin Neurobiol       Date:  2013-03-22       Impact factor: 6.627

10.  Chronic cigarette smoking: implications for neurocognition and brain neurobiology.

Authors:  Timothy C Durazzo; Dieter J Meyerhoff; Sara Jo Nixon
Journal:  Int J Environ Res Public Health       Date:  2010-10-21       Impact factor: 3.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.